Potential New Applications of Sodium-Glucose Cotransporter-2 Inhibitors Across the Continuum of Cancer-Related Cardiovascular Toxicity.

Although the difference in MRI-assessed fibrosis did not reach statistical significance—potentially due to the limited sample size—histological evaluation confirmed a lower extent of myocardial fibrosis in animals treated with 20 mg of empagliflozin, as reported by Medina-Hernández et al.

also in 111,027 other papers